SCHEMBL4755540

SCHEMBL4755540

N#CC(CC1C2CCC1CNC2)(c1ccccc1)C1CCCCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 1/20 0.41
KEAP1 Q14145 1/20 0.35
NFE2L2 Q16236 1/20 0.35
CHRM3 P20309 5/20 0.35
CYP2D6 P10635 5/20 0.35
CHRM2 P08172 4/20 0.35
CHRM1 P11229 4/20 0.35
KCNH2 Q12809 3/20 0.35
CHRM4 P08173 2/20 0.35
CHRM5 P08912 2/20 0.35
CYP3A4 P08684 2/20 0.35
NFKB1 P19838 2/20 0.35
GRIN2D O15399 1/20 0.35
GRIN3B O60391 1/20 0.35
HRH1 P35367 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2A Q12879 1/20 0.35
GRIN2B Q13224 1/20 0.35
GRIN2C Q14957 1/20 0.35
GRIN3A Q8TCU5 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4757759 0.80 CCR1 (0.43) CCR1CHRM3CHRM2CHRM1KCNA3
SCHEMBL4756747 0.79 CHRM3 (0.47) CHRM3CYP2D6CHRM2CHRM1OPRM1
SCHEMBL4755434 0.78 CHRM3 (0.41) CCR1KEAP1NFE2L2CHRM3CHRM2
SCHEMBL13123944 0.75 CCR1 (0.48) CCR1KEAP1NFE2L2CHRM3CYP2D6
SCHEMBL9665195 0.75 CCR1 (0.48) CCR1KEAP1NFE2L2CHRM3CYP2D6
SCHEMBL4756790 0.74 CHRM3 (0.39) CCR1CHRM3CYP2D6CHRM2CHRM1
SCHEMBL9667151 0.74 CCR1 (0.47) CCR1KEAP1NFE2L2CHRM3CYP2D6
SCHEMBL5754340 0.72 KEAP1 (0.47) CCR1KEAP1NFE2L2CHRM3CYP2D6
SCHEMBL5751962 0.72 CCR1 (0.46) CCR1KEAP1NFE2L2CHRM3CYP2D6
SCHEMBL8073914 0.70 CCR1 (0.45) CCR1KEAP1NFE2L2CHRM3CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008117229-A1 MUSCARINIC RECEPTOR ANTAGONISTS RANBAXY LABORATORIES LIMITED (IN) 2008-10-02 WO disclosed